Ginzac, Angeline
Thivat, Emilie http://orcid.org/0000-0001-6833-1971
Petorin, Caroline
Richard, Damien
Herviou, Pauline
Molnar, Ioana
Devaud, Hervé
Creveaux, Isabelle
Ferrer, Florent
Authier, Nicolas
Jary, Marine
Pezet, Denis
Durando, Xavier
Funding for this research was provided by:
Ligue Contre le Cancer (comité du Puy de Dôme, 2015)
Article History
Received: 6 July 2023
Accepted: 11 October 2023
First Online: 7 November 2023
Declarations
:
: The study protocol and its amendments obtained approval from the French National Agency for the safety of Medicines and Health Products on July 29, 2013 and from the Ethics Committee on September 15, 2013 (CPP Sud-Est VI, Clermont-Ferrand). The study is conducted in accordance with the Helsinki Declaration, the Good Clinical Practice (GCP) guidelines of the International Conference on Harmonisation (ICH–E6, 17/07/96), and local regulatory requirements. All the patients enrolled in the study signed written informed consent.
: The authors have no conflict of interest.